HCC

>

Latest News

First-Line Nivolumab/Ipilimumab Improves Survival in Hepatocellular Cancer
First-Line Nivolumab/Ipilimumab Improves Survival in Hepatocellular Cancer

March 20th 2024

Hope Beyond Surgery: Optimizing Care for Cholangiocarcinoma
Hope Beyond Surgery: Optimizing Care for Cholangiocarcinoma

February 15th 2024

Durvalumab/Bevacizumab/TACE Significantly Extends Survival in HCC
Durvalumab/Bevacizumab/TACE Significantly Extends Survival in HCC

February 6th 2024

FDA Fast Tracks BST02 for Liver Cancer
FDA Fast Tracks BST02 for Liver Cancer

February 2nd 2024

Video Series
Video Interviews
Podcasts

More News